Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
79 /100
CRITICAL RISK
Score updated Aug 28, 2026

CLRB — Cellectar Biosciences, Inc. Dilution Risk Tracker

Track CLRB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CLRB — Get alerts when the score changes →

As of August 28, 2026, Cellectar Biosciences, Inc. (CLRB) has a DilutionWatch DilutionScore of 79/100, rated CRITICAL dilution risk. Cellectar Biosciences, Inc. has a market capitalization of $25.09M, 9.45M shares outstanding, 19 institutional holders tracked. Stored dilution-related fields include 52.65M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
65
📊 Float Risk
30
⚠️ Warrant Exposure
90
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 37%
📜 Warrant Exercise model 60%
• Massive warrant overhang: 557% of shares outstanding
• Warrant risk score very high (90/100)
💰 Capital Raise model 15%
• Under 12 months cash (12mo)
📉 Score Deterioration model 15%
• Score already CRITICAL (79/100) — events likely imminent
🔔 Track CLRB — Get forecast alerts →

Market Data

Market Cap$25.09M
Shares Outstanding9.45M
Float7.82M
Cash$33.99M
Debt$330.2K
Short InterestN/A

Institutional Holdings

QoQ: ↑ 13.5% shares (2026Q1 vs prior)
19 institutional holders · 393.6K shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 163.8K shares
#2 Bleichroeder LP 100.0K shares
#3 GEODE CAPITAL MANAGEMENT, LLC 52.8K shares
+ 16 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest174.8K
Days to Cover3.9
% of Float2.2%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30
xbrl XBRL CONVERTIBLE 2023-12-31
Full SEC filing analysis available with free account

Recent News

No recent news

Factual CLRB Dilution Snapshot

Cellectar Biosciences, Inc. (CLRB) has a DilutionScore of 79/100, rated Critical dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track CLRB Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CLRB — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for CLRB
CLRB FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.